Evidence map›Paper›PMID 42877010›Full record

ArticleJournal of contemporary brachytherapy2026

Comprehensive clinical dosimetry in contact skin interventional radiotherapy (modern brachytherapy): Practical tips and tricks.

Bruno Fionda, Enrico Rosa, Elisa Placidi, Valentina Lancellotta, Pierpaolo Dragonetti, Maria Concetta La Milia, Martina De Angeli, Francesco Pastore, Mariangela Massaccesi, Piotr Wojcieszek and 4 more

Abstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bruno FiondaUOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Enrico RosaUOC Fisica per le Scienze della Vita, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Elisa PlacidiUOC Fisica per le Scienze della Vita, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Valentina LancellottaUOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Pierpaolo DragonettiUOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Maria Concetta La MiliaUOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Martina De AngeliUOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Francesco PastoreUOC Servizio di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Mariangela MassaccesiUOC Servizio di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Piotr WojcieszekBrachytherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.
Frank-André SiebertClinic of Radiotherapy, University Hospital of Schleswig-Holstein, Campus Kiel, Germany.
Maria Antonietta GambacortaUOC Servizio di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Marco De SpiritoUOC Fisica per le Scienze della Vita, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Luca TagliaferriUOC Degenze di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Contact interventional radiotherapy (cIRT) is an effective option for non-melanoma skin cancers, particularly in anatomically complex sites, where organ preservation, functional results, and cosmetic outcomes are relevant. This paper summarized practical dosimetric considerations in cIRT, focusing on the therapeutic window, surface curvature, boluses and air gaps, dose calculation algorithms, and 3D-printed devices. Material and methods: Key physical and clinical factors affecting dose distribution were analyzed from recent literature, including prescription depth, source-to-skin distance, applicator geometry, tissue interfaces, and patient-specific device design. Results: Therapeutic window is influenced by target thickness, source-to-skin distance, and surface curvature. Multilayer and intensity-modulated arrangements may improve target coverage while limiting superficial hotspots. Bolus and air gaps can modify local dose distribution, especially in irregular anatomical regions, while model-based algorithms better account for heterogeneities and interfaces than TG-43. 3D-printed applicators may further enhance conformity, reproducibility, and organs at risk sparing. Conclusions: Although clinically non-invasive, cIRT requires careful dosimetric optimization. Appropriate management of applicator geometry, dose calculation, bolus, air gaps, and patient-specific devices, may improve treatment accuracy, target coverage, and toxicity control.

Indexed as

brachytherapycontactHDRinterventional radiotherapynon-melanoma skin cancer

Identifiers

PMID42877010
PMCPMC13662458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.